ENTITY

Vigonvita Life Sciences (VVL HK)

11
Analysis
Health Care • China

bullish•Alibaba
•11 Aug 2025 08:08

ECM Weekly (11 August 2025)-Bharti, Eternal, Paytm, LG CNS, Guming, JSW, Bluestone, SICC, Roborock

Aequitas Research's weekly update on the IPOs, placements, lockup expiry and other ECM linked events that were covered by the team over the past week.

Logo
831 Views
Share
•05 Aug 2025 15:26

Vigonvita Life Sciences (旺山旺水) Pre-IPO: Structural Challenges for Commercialization

​Vigonvita seeks to raise $100 million in Hong Kong IPO with CITIC as book runner. We look at changes in the company's assets and progresses. We...

Logo
474 Views
Share
•29 May 2025 08:55

Pre-IPO Vigonvita Life Sciences - The Challenges Behind the Pipeline and the Outlook

Vigonvita's valuation hinges on innovative drug pipeline but excluding COVID-19 project. Series C financing boosts post-money valuation to RMB4.45...

Logo
589 Views
Share
bullish•Japan Post Bank
•03 Mar 2025 07:45

ECM Weekly (3rd Mar 2025) - Japan Post Bank, JX Advance, Mixue, Chifeng, JSW Cement, Premier, Guzman

Aequitas Research's weekly update on the IPOs, placements, lockup expiry and other ECM linked events that were covered by the team over the past week.

Logo
748 Views
Share
•26 Feb 2025 10:27

Vigonvita Life Sciences (旺山旺水) Pre-IPO Tearsheet

​Vigonvita seeks US$100M in Hong Kong IPO for COVID-19 drug expansion. It has commercialized COVID-19 drugs in the past and is looking to expand...

Logo
490 Views
Share
x